AAIS
DGX icon

ABN AMRO Investment Solutions’s Quest Diagnostics DGX Stock Holding History

ABN AMRO Investment Solutions’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21M Buy
98,878
+22,518
+29% +$4.42M 0.18% 92
2026
Q1 		$15M Buy
76,360
+4,098
+6% +$796K 0.2% 101
2025
Q4 		$12.5M Sell
72,262
-8,519
-11% -$1.55M 0.19% 100
2025
Q3 		$15.4M Sell
80,781
-15,567
-16% -$2.76M 0.32% 65
2025
Q2 		$17.3M Buy
96,348
+12,635
+15% +$2.19M 0.35% 60
2025
Q1 		$14.2M Buy
83,713
+10,228
+14% +$1.68M 0.3% 75
2024
Q4 		$11.1M Buy
73,485
+8,193
+13% +$1.27M 0.21% 91
2024
Q3 		$10.1M Buy
65,292
+271
+0.4% +$40.5K 0.18% 99
2024
Q2 		$8.9M Sell
65,021
-1,380
-2% -$189K 0.16% 109
2024
Q1 		$8.84M Buy
66,401
+1,178
+2% +$153K 0.15% 113
2023
Q4 		$8.99M Sell
65,223
-3,458
-5% -$455K 0.16% 119
2023
Q3 		$8.37M Sell
68,681
-48,071
-41% -$6.4M 0.16% 117
2023
Q2 		$16.4M Sell
116,752
-14,573
-11% -$2.01M 0.33% 78
2023
Q1 		$18.6M Buy
+131,325
New +$18.8M 0.38% 73

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

ABN AMRO Investment Solutions's DGX Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Quest Diagnostics (DGX) stake by 29% in Q2 2026, buying an estimated $4.42M and bringing the position to 98,878 shares worth $21M. The position accounts for 0.18% of the portfolio, ranked #92.

ABN AMRO Investment Solutions first reported a position in DGX in Q1 2023 and has held it in 14 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • ABN AMRO Investment Solutions held 98,878 shares of Quest Diagnostics worth $21M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 22,518 Quest Diagnostics shares in Q2 2026, an estimated $4.42M.
  • Quest Diagnostics made up 0.18% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #92 holding.
  • ABN AMRO Investment Solutions first reported a position in Quest Diagnostics in Q1 2023 and has held it in 14 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.